Advanced Search
DSpace@MIT

Cell and nanomaterial-based approaches for diagnosis and chemotherapy of metastatic cancer cells

Research and Teaching Output of the MIT Community

Show simple item record

dc.contributor.advisor Angela M. Belcher. en_US
dc.contributor.author Kohli, Aditya (Aditya Gobind) en_US
dc.contributor.other Massachusetts Institute of Technology. Dept. of Biological Engineering. en_US
dc.date.accessioned 2011-02-23T14:19:30Z
dc.date.available 2011-02-23T14:19:30Z
dc.date.copyright 2010 en_US
dc.date.issued 2010 en_US
dc.identifier.uri http://hdl.handle.net/1721.1/61142
dc.description Thesis (M. Eng.)--Massachusetts Institute of Technology, Biological Engineering Division, 2010. en_US
dc.description Cataloged from PDF version of thesis. en_US
dc.description Includes bibliographical references (p. 58-63). en_US
dc.description.abstract Metastasis is a multistep process during which tumor cells separate from a primary tumor, penetrate the bloodstream, evade host defenses, and colonize distant organs. This final and fatal step in tumor development is the cause of more than 90% of cancer related deaths. Therapies and diagnostics can be targeted to metastasis at three points in its progression: the primary tumor, the secondary tumor, and circulating tumor cells (CTCs). While much work has focused on primary tumors, less effort has concentrated on targeted isolation, detection and therapy of deeply penetrated metastases and CTCs. Here, I discuss cell and nanomaterial-based approaches for detecting and ablating these malignant populations. The number of CTCs in the blood directly correlates with disease progression; however, the lack of definitive markers has limited their isolation and characterization. I have demonstrated the potential use of platelets as a cell-based marker for isolation and detection of CTCs. Using phage display technology, it was possible to identify candidate peptides specific to mesenchymal-like tumor cells that may mimic the motile and aggressive CTC population. In order to detect and ablate metastases and CTCs, M13 bacteriophage was engineered into a platform for simultaneous tumor targeting, imaging, and therapy. Single-walled carbon nanotubes (SWNTs) and doxorubicin, a chemotherapeutic agent, were loaded on phage for fluorescent near-infrared imaging and cytotoxicity of metastatic lesions, respectively. The near-infrared optical properties of SWNTs in the "second window" make them promising candidates for imaging nascent and deeply seeded tumors. This approach provides an 'all-in-one' platform for targeted fluorescence imaging and efficient drug delivery and may allow for real-time monitoring of tumor response to drug regimens. en_US
dc.description.statementofresponsibility by Aditya Kohli. en_US
dc.format.extent 63 p. en_US
dc.language.iso eng en_US
dc.publisher Massachusetts Institute of Technology en_US
dc.rights M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission. en_US
dc.rights.uri http://dspace.mit.edu/handle/1721.1/7582 en_US
dc.subject Biological Engineering. en_US
dc.title Cell and nanomaterial-based approaches for diagnosis and chemotherapy of metastatic cancer cells en_US
dc.type Thesis en_US
dc.description.degree M.Eng. en_US
dc.contributor.department Massachusetts Institute of Technology. Dept. of Biological Engineering. en_US
dc.identifier.oclc 698091069 en_US


Files in this item

Name Size Format Description
698091069.pdf 9.966Mb PDF Preview, non-printable (open to all)
698091069-MIT.pdf 9.966Mb PDF Full printable version (MIT only)

This item appears in the following Collection(s)

Show simple item record

MIT-Mirage